National Guideline Clearinghouse | Fingolimod for the treatment of highly active relapsing-remitting multiple sclerosis.

National Institute for Health and Clinical Excellence (NICE) ► full-text:
National Guideline Clearinghouse | Fingolimod for the treatment of highly active relapsing-remitting multiple sclerosis.

Guideline Title

Fingolimod for the treatment of highly active relapsing-remitting multiple sclerosis.

 

 

Bibliographic Source(s)

National Institute for Health and Clinical Excellence (NICE). Fingolimod for the treatment of highly active relapsing-remitting multiple sclerosis. London (UK): National Institute for Health and Clinical Excellence (NICE); 2012 Apr. 55 p. (Technology appraisal guidance; no. 254).

 

 

Guideline Status

This is the current release of the guideline.